Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Only 12/200 (6%) of women with breast cancer reported using vitamin D supplements.Sociodemographic, Reproductive, and Fracture-Associated Characteristics of BCS and PK-VF Study CohortsVariableBCS CohortPK-VF CohortAge years57.5 ± 4.957.5 ± 4.9BMI kg/m224.8 ± 3.724.7 ± 3.2Education ≥ High School156/200 (78)c91/197 (46.1)Smoking, Ever6/200 (3)5/200 (2.5)Current Alcohol Use11/200 (5.5)8/200 (4.0)Menarche years14.4 ± 2.0b15.1 ± 2.4Menopause years49.4 ± 4.049.6 ± 3.5Parity 02/200 (1%)2/190 (1.6) 1137/200 (68.5)b102/190 (53.7) ≥ 261/200 (30.5)a85/190 (44.7)Fall in Past Year31/198 (15.7): Parental Fracture History20/188 (10.6)31/200 (15.5)Personal Fracture History21/200 (10.5)b42/200 (21)Calcium Supplement Use96/196 (49.0)a73/198 (36.9)Vitamin D Supplement Use12/200 (6.0%): CTx ng/mL0.458 ± 0.2110.441 ± 0.199P1NP ng/mL61.1 ± 30.456.3 ± 24.625OHD ng/mL20.3 ± 7.8c13.3 ± 5.7Values for continuous variables are reported as mean ± SD and for categorical values as n/N(%)PK-VF Peking Vertebral Fracture study, BCS breast cancer survivors, CTx serum β-c-terminal telopeptide of type 1 collagen, P1NP pro-collagen type 1 N propeptide, 25OHD 25-hydroxy vitamin D, kg kilograms, m meters, ng nanograms, mL millilitersa < .05b < .01c < .001

Source: Sociodemographic, reproductive and fracture-associated characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps

Source: Article title.

Initially women were recruited by screening the CHCAMS medical database for women diagnosed with breast cancer at CHCAMS prior to January 1, 2008.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps

Cross-sectional study · BMC Cancer · 2018

Original publication title

Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps

Evelyn Hsieh; Qin Wang; Renzhi Zhang; Xin Niu; Weibo Xia; Liana Fraenkel; Karl L. Insogna; Jing Li; Jennifer S. Smith; Chunwu Zhou; You-lin Qiao; Pin Zhang

© The Author(s). 2018

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Despite a four-fold increased odds of prevalent vertebral fracture among Chinese breast cancer survivors in our study, rates of screening for osteoporosis and fracture risk were low reflecting a lack of standardization of care regarding cancer-treatment induced bone loss.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Breast cancer survivors are at high risk for fracture due to cancer treatment-induced bone loss, however, data is scarce regarding the scope of this problem from an epidemiologic and health services perspective among Chinese women with breast cancer.

Source: Background

Abstract: What methods does the paper describe?

We designed a cross-sectional study comparing prevalence of vertebral fractures among age: and BMI-matched women from two cohorts. Women in the Breast Cancer Survivors cohort were enrolled from a large cancer hospital in Beijing. Eligibility criteria included age 50 to 70 years, initiation of treatment for breast cancer at least 5 years prior to enrollment, and no history of metabolic bone disease or bone metastases. Data collected included sociodemographic characteristics; fracture-related risk factors, screening and preventive measures; breast cancer history; and thoracolumbar x-ray.

The matched comparator group was selected from participants enrolled in the Peking Vertebral Fracture Study, an independent cohort of healthy community-dwelling postmenopausal women from Beijing.

Source: Methods

Abstract: Results

Two hundred breast cancer survivors were enrolled (mean age 57.5 ± 4.9 years), and compared with 200 matched healthy women. Twenty-two (11%) vertebral fractures were identified among breast cancer survivors compared with 7 (3.5%) vertebral fractures in the comparison group, yielding an adjusted odds ratio for vertebral fracture of 4.16 (95%CI 1.69 to 10.21, p < 0.01). The majority had early stage (85.3%) and estrogen and/or progesterone receptor positive (84.6%) breast cancer. Approximately half of breast cancer survivors reported taking calcium supplements, 6.1% reported taking vitamin D supplements, and only 27% reported having a bone density scan since being diagnosed with breast cancer.

Source: Results

Abstract: Conclusions

Despite a four-fold increased odds of prevalent vertebral fracture among Chinese breast cancer survivors in our study, rates of screening for osteoporosis and fracture risk were low reflecting a lack of standardization of care regarding cancer-treatment induced bone loss.

Source: Conclusions
Authors’ abstract

Background

Breast cancer survivors are at high risk for fracture due to cancer treatment-induced bone loss, however, data is scarce regarding the scope of this problem from an epidemiologic and health services perspective among Chinese women with breast cancer.

Methods

We designed a cross-sectional study comparing prevalence of vertebral fractures among age: and BMI-matched women from two cohorts. Women in the Breast Cancer Survivors cohort were enrolled from a large cancer hospital in Beijing. Eligibility criteria included age 50 to 70 years, initiation of treatment for breast cancer at least 5 years prior to enrollment, and no history of metabolic bone disease or bone metastases. Data collected included sociodemographic characteristics; fracture-related risk factors, screening and preventive measures; breast cancer history; and thoracolumbar x-ray.

The matched comparator group was selected from participants enrolled in the Peking Vertebral Fracture Study, an independent cohort of healthy community-dwelling postmenopausal women from Beijing.

Results

Two hundred breast cancer survivors were enrolled (mean age 57.5 ± 4.9 years), and compared with 200 matched healthy women. Twenty-two (11%) vertebral fractures were identified among breast cancer survivors compared with 7 (3.5%) vertebral fractures in the comparison group, yielding an adjusted odds ratio for vertebral fracture of 4.16 (95%CI 1.69 to 10.21, p < 0.01). The majority had early stage (85.3%) and estrogen and/or progesterone receptor positive (84.6%) breast cancer. Approximately half of breast cancer survivors reported taking calcium supplements, 6.1% reported taking vitamin D supplements, and only 27% reported having a bone density scan since being diagnosed with breast cancer.

Conclusions

Despite a four-fold increased odds of prevalent vertebral fracture among Chinese breast cancer survivors in our study, rates of screening for osteoporosis and fracture risk were low reflecting a lack of standardization of care regarding cancer-treatment induced bone loss.

Publication and source details

Original title: Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps

Evelyn Hsieh; Qin Wang; Renzhi Zhang; Xin Niu; Weibo Xia; Liana Fraenkel; Karl L. Insogna; Jing Li; Jennifer S. Smith; Chunwu Zhou; You-lin Qiao; Pin Zhang

BMC Cancer · 2018

© The Author(s). 2018https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.http://dx.doi.org/10.13039/100000061Fogarty International CenterR25 TW009340Hsieh Evelyn http://dx.doi.org/10.13039/100000069National Institute of Arthritis and Musculoskeletal and Skin DiseasesK24 AR060231-01Fraenkel Liana

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T22:04:05.710865+00:00

DOI: 10.1186/s12885-018-4014-5 · PMC5789645